Matt Dormer is a Managing Director in the Health & Life Sciences group in the Boston office of Stephens Inc.
Mr. Dormer joined Stephens in 2022 and has more than 20 years of experience in the biotechnology industry. Prior to joining Stephens, he was a Managing Director in Healthcare Investment Banking at Oppenheimer & Co., Laidlaw & Co. and Summer Street Research Partners. He has extensive experience assisting Healthcare companies, both publics and privates, with significant transactions including M&A, IPOs, public offerings, private placements, ATMs, SPACs, convertible debt and a diverse spectrum of strategic and financial advisory assignments. Mr. Dormer started his financial career in Equity Research at Fulcrum Global Partners covering the Biotech sector before transitioning to Investment Banking. He earned a Bachelor of Science in Biology from Davidson College and received a Master of Business Administration in Finance from Northeastern University.